1. Home
  2. Board Of Regents, The University Of Texas System Patent Portfolio Statistics

Board Of Regents, The University Of Texas System Patent Portfolio Statistics

Board Of Regents, The University Of Texas System

Board Of Regents, The University Of Texas System`s Profile

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Board Of Regents, The University Of Texas System look like?

Total Applications: 3605
Granted Patents: 2017
Grant Index 66.77 %
Abandoned/Rejected Applications: 1004 (33.23%)
In-Process Applications: 570
Average Grant Time: 3.26 Years
Average Office Actions: 1.98

Which Technology Area Board Of Regents, The University Of Texas System is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
Opap Parked GAU 175
1642 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 147
1643 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 73
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 72
1618 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs 62

How many patents are Board Of Regents, The University Of Texas System filing every year?

Year Total Applications
2022 0*
2021 123*
2020 195
2019 177
2018 189

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Board Of Regents, The University Of Texas System in USPTO?

Publication number: US20210268050A1

Abstract:
Disclosed herein, in certain embodiments, is a method of inhibiting or treating a cancer with use of a TNF expressing myxoma virus. Also disclosed herein are methods of inhibiting or treating a cancer with use of a mononuclear peripheral blood cells and/or a bone marrow cells treated with a TNF-expressing myxoma virus. Some aspects relate to engineered myxoma virus and pharmaceutical compositions for use with one or more of the methods described herein.

Publication date: 2021-09-02
Applicant: Board Of Regents, The University Of Texas System
Inventors: Douglas Grant Mcfadden


Publication number: US20210049861A1

Abstract:
A video gaming machine provides partial symbols that match other partial symbols across adjacent horizontal frames. Matches of two melding frames provides absolute payouts, multipliers, bonus events and the like.

Publication date: 2021-02-18
Applicant: Board Of Regents, The University Of Texas System
Inventors: Daniel Sahl


Publication number:

Abstract:
None

Publication date:
Applicant: Board Of Regents, The University Of Texas System
Inventors: Chen Zhou


How are Board Of Regents, The University Of Texas System’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17259849 Methods Of Treating Cancer With Tnf Expressing Myxoma Virus Docketed New Case – Ready for Examination OPAP Central, Docket
16939164 Electronic Gaming Machine With Potential Matching Segments In Adjacent Horizontal Frames Non Final Action Mailed 3715 Yen, Jason Tahai
63040513 Systems For Removing Oxidized Contaminants From Water And Related Methods
16759297 System For Improving Mine Safety And A Method For Using Same Response to Non-Final Office Action Entered and Forwarded to Examiner 3683 Nguyen, Nga B
16626016 A Universal Platform To Enhance Crispr-Based Gene Editing For In Vivo Therapies Docketed New Case – Ready for Examination OPAP Central, Docket